Related Experiment Videos
[Detection of primary aldosteronism using the captopril test]
K Pirich1, H Vierhapper, W Graninger
1Abteilung für Klinische Endokrinologie und Diabetologie, I. Medizinische Universitätsklinik, Wien.
Wiener Klinische Wochenschrift
|September 11, 1987
Summary
The captopril test effectively diagnoses primary aldosteronism by measuring plasma aldosterone changes. This outpatient test helps identify conditions like adrenal hyperplasia and aldosterone-producing adenoma.
Area of Science:
- Endocrinology
- Hypertension Research
- Diagnostic Testing
Context:
- Primary aldosteronism is a significant cause of secondary hypertension.
- Accurate diagnosis is crucial for appropriate management and preventing complications.
- Current diagnostic methods may require invasive procedures or extensive preparation.
Purpose:
- To evaluate the diagnostic utility of the captopril test for primary aldosteronism.
- To assess changes in plasma aldosterone levels after captopril administration.
- To determine the feasibility of this test in an outpatient setting.
Summary:
- The study investigated the plasma aldosterone response to oral captopril (25 mg) in healthy subjects and hypertensive patients.
- In healthy individuals and those with essential hypertension, captopril significantly decreased plasma aldosterone.
- Patients with primary aldosteronism showed elevated post-captopril aldosterone levels, indicating the test's diagnostic potential, despite one false-negative result.
Impact:
- The captopril test offers a valuable, non-invasive outpatient method for diagnosing primary aldosteronism.
- This diagnostic approach can aid in identifying patients with specific adrenal disorders.
- Improved diagnostic capabilities can lead to timely and targeted therapeutic interventions for hypertension.